Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

444 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.
Costa LJ, Maddocks K, Epperla N, Reddy NM, Karmali R, Umyarova E, Bachanova V, Costa C, Glenn MJ, Chavez JC, Calzada O, Lansigan F, Nasheed H, Barta SK, Zhou Z, Jaglal M, Chhabra S, Hernandez-Ilizaliturri F, Xavier AC, Mehta A, Peker D, Forero-Torres A, Al-Mansour Z, Evens AM, Cohen JB, Flowers CR, Fenske TS, Hamadani M. Costa LJ, et al. Among authors: flowers cr. Am J Hematol. 2017 Feb;92(2):161-170. doi: 10.1002/ajh.24615. Am J Hematol. 2017. PMID: 27880984 Free PMC article.
Maintenance therapy in lymphoma.
Mihelic R, Kaufman J, Lonial S, Flowers C. Mihelic R, et al. Clin Lymphoma Myeloma. 2007 Sep;7(8):507-13. doi: 10.3816/clm.2007.n.034. Clin Lymphoma Myeloma. 2007. PMID: 18021467 Review.
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.
de Vos S, Goy A, Dakhil SR, Saleh MN, McLaughlin P, Belt R, Flowers CR, Knapp M, Hart L, Patel-Donnelly D, Glenn M, Gregory SA, Holladay C, Zhang T, Boral AL. de Vos S, et al. Among authors: flowers cr. J Clin Oncol. 2009 Oct 20;27(30):5023-30. doi: 10.1200/JCO.2008.17.7980. Epub 2009 Sep 21. J Clin Oncol. 2009. PMID: 19770386 Clinical Trial.
Novel agents for diffuse large B-cell lymphoma.
Sinha R, DeJoubner N, Flowers C. Sinha R, et al. Expert Opin Investig Drugs. 2011 May;20(5):669-80. doi: 10.1517/13543784.2011.565745. Epub 2011 Mar 28. Expert Opin Investig Drugs. 2011. PMID: 21443388 Review.
Pharmacokinetic-directed high-dose busulfan combined with cyclophosphamide and etoposide results in predictable drug levels and durable long-term survival in lymphoma patients undergoing autologous stem cell transplantation.
Zhang H, Graiser M, Hutcherson DA, Dada MO, McMillan S, Ali Z, Flowers CR, Waller EK. Zhang H, et al. Among authors: flowers cr. Biol Blood Marrow Transplant. 2012 Aug;18(8):1287-94. doi: 10.1016/j.bbmt.2012.02.006. Epub 2012 Feb 25. Biol Blood Marrow Transplant. 2012. PMID: 22370160 Free article.
Characteristics and outcomes of diffuse large B-cell lymphoma presenting in leukaemic phase.
Muringampurath-John D, Jaye DL, Flowers CR, Saxe D, Chen Z, Lechowicz MJ, Weisenburger DD, Bast M, Arellano ML, Bernal-Mizrachi L, Heffner LT, McLemore M, Kaufman JL, Winton EF, Lonial S, Armitage JO, Khoury HJ. Muringampurath-John D, et al. Among authors: flowers cr. Br J Haematol. 2012 Sep;158(5):608-14. doi: 10.1111/j.1365-2141.2012.09209.x. Epub 2012 Jul 4. Br J Haematol. 2012. PMID: 22758202 Free article.
444 results